The inhibitors of ENTs modulate a variety of physiological processes by changing the extracellular adenosine concentrations and ENT inhibitors have a well-established role in the treatment of many diseases including cancer, HIV, and cardiovascular diseases (King et al., 2006; Jordheim et al., 2013). Here, NT5E is linked to cardiovascular disorder.